Intuitive Surgical, Inc. $ISRG Shares Bought by Perennial Investment Advisors LLC

Perennial Investment Advisors LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.9% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,587 shares of the medical equipment provider’s stock after purchasing an additional 166 shares during the period. Perennial Investment Advisors LLC’s holdings in Intuitive Surgical were worth $1,406,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Nuveen LLC acquired a new position in Intuitive Surgical in the first quarter worth approximately $1,715,899,000. Vanguard Group Inc. grew its holdings in shares of Intuitive Surgical by 2.1% in the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock worth $18,115,025,000 after acquiring an additional 670,302 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of Intuitive Surgical by 26.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider’s stock worth $1,396,496,000 after acquiring an additional 584,375 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Intuitive Surgical by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after purchasing an additional 566,979 shares during the period. Finally, Jennison Associates LLC raised its holdings in Intuitive Surgical by 20.4% during the 2nd quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock worth $1,696,738,000 after buying an additional 528,359 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insider Activity

In related news, EVP Brian Edward Miller sold 3,500 shares of the firm’s stock in a transaction on Monday, November 10th. The shares were sold at an average price of $575.00, for a total value of $2,012,500.00. Following the transaction, the executive vice president directly owned 5,758 shares in the company, valued at approximately $3,310,850. This trade represents a 37.81% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP Fredrik Widman sold 2,067 shares of the company’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $550.00, for a total transaction of $1,136,850.00. Following the sale, the vice president owned 473 shares of the company’s stock, valued at $260,150. This trade represents a 81.38% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders have sold 116,164 shares of company stock valued at $61,916,172. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Up 0.0%

NASDAQ ISRG opened at $546.77 on Wednesday. The stock has a market capitalization of $196.00 billion, a PE ratio of 72.32, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The company has a 50 day moving average price of $485.63 and a two-hundred day moving average price of $503.34.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same quarter in the prior year, the business posted $1.84 EPS. Intuitive Surgical’s quarterly revenue was up 22.9% on a year-over-year basis. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on the stock. Argus lifted their target price on shares of Intuitive Surgical from $600.00 to $630.00 in a research report on Monday, October 27th. Deutsche Bank Aktiengesellschaft restated a “sell” rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Erste Group Bank reiterated a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Finally, Piper Sandler raised their price objective on Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Two analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.